170 related articles for article (PubMed ID: 10339645)
1. Making sense of multimodality therapy for esophageal cancer.
Krasna MJ; Mao YS
Surg Oncol Clin N Am; 1999 Apr; 8(2):259-78. PubMed ID: 10339645
[TBL] [Abstract][Full Text] [Related]
2. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
[TBL] [Abstract][Full Text] [Related]
3. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy of esophageal cancer.
Ilson DH; Bains M; Ginsberg RJ; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):723-40. PubMed ID: 9309090
[TBL] [Abstract][Full Text] [Related]
5. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
Varadhachary G; Ajani JA
Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
[TBL] [Abstract][Full Text] [Related]
6. [Radiotherapy for locally advanced esophageal cancer].
Fukuhara N; Karasawa K; Kaneyasu Y; Kita-Okawa M; Okawa T
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1841-8. PubMed ID: 9797806
[TBL] [Abstract][Full Text] [Related]
7. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
[TBL] [Abstract][Full Text] [Related]
8. Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Elsaleh H; Farrell JJ; Crane CH
J Gastroenterol Hepatol; 2009 May; 24(5):708-10. PubMed ID: 19646012
[No Abstract] [Full Text] [Related]
9. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
Tanaka A; Ishikawa S; Okuno K; Shiozaki H
Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
[TBL] [Abstract][Full Text] [Related]
10. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
An FS; Huang JQ; Xie YT; Chen SH; Rong TH
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
[TBL] [Abstract][Full Text] [Related]
11. [Principles of treatment in locally advanced esophageal squamous cancer].
Constantinoiu S; Hanna A; Bîrlă R; Anghel R; Tavlas E; Mocanu A; Hoară P
Chirurgia (Bucur); 2010; 105(1):7-14. PubMed ID: 20405674
[TBL] [Abstract][Full Text] [Related]
12. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.
Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT
Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809
[TBL] [Abstract][Full Text] [Related]
13. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
[TBL] [Abstract][Full Text] [Related]
14. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].
Fujita H; Sueyoshi S; Tanaka T; Toh U; Mine T; Sasahara H; Shirouzu K; Yamana H; Toda Y; Hayabuchi N
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2016-22. PubMed ID: 11103231
[TBL] [Abstract][Full Text] [Related]
15. Reduced incidence of nodal micrometastasis after major response to neoadjuvant chemoradiation in locally advanced esophageal cancer.
Prenzel KL; König A; Schneider PM; Schnickmann C; Baldus SE; Schröder W; Bollschweiler E; Dienes HP; Mueller RP; Izbicki JR; Hölscher AH
Ann Surg Oncol; 2007 Feb; 14(2):954-9. PubMed ID: 17103071
[TBL] [Abstract][Full Text] [Related]
16. [A case of advanced esophageal cancer resected curatively by preoperative chemotherapy with cisplatin].
Ohyama S; Noto H; Fujita H; Miyazaki I
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2861-3. PubMed ID: 3753030
[TBL] [Abstract][Full Text] [Related]
17. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
19. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]